Verastem
VSTM
58 hedge funds and large institutions have $136M invested in Verastem in 2023 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 15 increasing their positions, 12 reducing their positions, and 4 closing their positions.
107% more call options, than puts
Call options by funds: $31K | Put options by funds: $15K
25% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 4
25% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 12
2% more funds holding
Funds holding: 57 → 58 (+1)
0% less capital invested
Capital invested by funds: $136M → $136M (-$373K)
0.32% less ownership
Funds ownership: 66.34% → 66.01% (-0.32%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.01M |
| 2 |
Morgan Stanley
New York
|
+$951K |
| 3 |
Millennium Management
New York
|
+$597K |
| 4 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$562K |
| 5 |
ECM
ExodusPoint Capital Management
New York
|
+$369K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$2.28M |
| 2 |
TCM
Tang Capital Management
San Diego,
California
|
-$1.08M |
| 3 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$676K |
| 4 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
-$168K |
| 5 |
Two Sigma Investments
New York
|
-$162K |
VSTM Hedge Fund Activity: Q4 2023 in Review
58 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in Verastem (VSTM) for Q4 2023, worth a combined $136M — down 0.27% from $136M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new VSTM positions and 4 closed out — a net gain of 1 holder — while 15 added to existing stakes and 12 trimmed.
The largest buyer was Susquehanna International Group, adding an estimated $1.01M. The largest seller was Citadel Advisors, cutting an estimated $2.28M.
- 58 institutional investors held Verastem (VSTM) as of Q4 2023, up from 57 in Q3 2023.
- Funds reported $136M of Verastem stock for Q4 2023, down 0.27% quarter-over-quarter.
- 5 funds opened new Verastem positions in Q4 2023 and 4 closed out, a net change of +1 holder.
- The largest Verastem buyer in Q4 2023 was Susquehanna International Group, an estimated $1.01M added.
- The largest Verastem seller in Q4 2023 was Citadel Advisors, an estimated $2.28M sold.
Based on aggregated 13F filings for Q4 2023.